TIGIT and neoplasm: No significant difference in effector cytokine production or degranulation between TIGIT+ and TIGIT− PM21-NK cells was observed in response to cytokine stimulation with IL-12/15/18 (Supplementary Materials Figure S4), indicating this greater function is specific to anti-tumor response.